112 related articles for article (PubMed ID: 12518775)
1. Receptor-dependent and genomic-independent actions of estrogen in vascular protection.
Lau YT
Chang Gung Med J; 2002 Oct; 25(10):636-44. PubMed ID: 12518775
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
Stirone C; Boroujerdi A; Duckles SP; Krause DN
Mol Pharmacol; 2005 Jan; 67(1):105-13. PubMed ID: 15496504
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase.
Simoncini T; Genazzani AR
J Clin Endocrinol Metab; 2000 Aug; 85(8):2966-9. PubMed ID: 10946913
[TBL] [Abstract][Full Text] [Related]
4. Role of gender and estrogen receptors in the rat aorta endothelium-dependent relaxation to red wine polyphenols.
Kane MO; Anselm E; Rattmann YD; Auger C; Schini-Kerth VB
Vascul Pharmacol; 2009; 51(2-3):140-6. PubMed ID: 19520189
[TBL] [Abstract][Full Text] [Related]
5. The vascular protective effects of estrogen.
Farhat MY; Lavigne MC; Ramwell PW
FASEB J; 1996 Apr; 10(5):615-24. PubMed ID: 8621060
[TBL] [Abstract][Full Text] [Related]
6. Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology.
Kypreos KE; Zafirovic S; Petropoulou PI; Bjelogrlic P; Resanovic I; Traish A; Isenovic ER
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):256-68. PubMed ID: 24414281
[TBL] [Abstract][Full Text] [Related]
7. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae.
Kim HP; Lee JY; Jeong JK; Bae SW; Lee HK; Jo I
Biochem Biophys Res Commun; 1999 Sep; 263(1):257-62. PubMed ID: 10486286
[TBL] [Abstract][Full Text] [Related]
8. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation.
Florian M; Lu Y; Angle M; Magder S
Steroids; 2004 Sep; 69(10):637-45. PubMed ID: 15465108
[TBL] [Abstract][Full Text] [Related]
9. 17Beta-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-alpha and -beta.
Gargett CE; Zaitseva M; Bucak K; Chu S; Fuller PJ; Rogers PA
J Clin Endocrinol Metab; 2002 Sep; 87(9):4341-9. PubMed ID: 12213896
[TBL] [Abstract][Full Text] [Related]
10. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase.
Hwang YP; Kim HG; Hien TT; Jeong MH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2011 Nov; 257(1):48-58. PubMed ID: 21884717
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.
Ma XL; Gao F; Yao CL; Chen J; Lopez BL; Christopher TA; Disa J; Gu JL; Ohlstein EH; Yue TL
J Pharmacol Exp Ther; 2000 Nov; 295(2):786-92. PubMed ID: 11046119
[TBL] [Abstract][Full Text] [Related]
12. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption.
Rubanyi GM; Freay AD; Kauser K; Sukovich D; Burton G; Lubahn DB; Couse JF; Curtis SW; Korach KS
J Clin Invest; 1997 May; 99(10):2429-37. PubMed ID: 9153286
[TBL] [Abstract][Full Text] [Related]
13. Estrogen modulation of endothelial nitric oxide synthase.
Chambliss KL; Shaul PW
Endocr Rev; 2002 Oct; 23(5):665-86. PubMed ID: 12372846
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway.
Wade CB; Robinson S; Shapiro RA; Dorsa DM
Endocrinology; 2001 Jun; 142(6):2336-42. PubMed ID: 11356680
[TBL] [Abstract][Full Text] [Related]
15. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
Geraldes P; Sirois MG; Tanguay JF
Circ Res; 2003 Sep; 93(5):399-405. PubMed ID: 12893737
[TBL] [Abstract][Full Text] [Related]
16. Genomic and non-genomic effects of estrogens on endothelial cells.
Simoncini T; Mannella P; Fornari L; Caruso A; Varone G; Genazzani AR
Steroids; 2004 Aug; 69(8-9):537-42. PubMed ID: 15288766
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17 beta-estradiol's effects on vascular biology.
Joswig M; Hach-Wunderle V; Ziegler R; Nawroth PP
Exp Clin Endocrinol Diabetes; 1999; 107(8):477-87. PubMed ID: 10612478
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.
Simoncini T; Mannella P; Fornari L; Varone G; Caruso A; Genazzani AR
Endocrinology; 2003 Aug; 144(8):3449-55. PubMed ID: 12865324
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells.
Iantorno M; Chen H; Kim JA; Tesauro M; Lauro D; Cardillo C; Quon MJ
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E756-64. PubMed ID: 17106060
[TBL] [Abstract][Full Text] [Related]
20. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration.
Simoncini T; Fornari L; Mannella P; Varone G; Caruso A; Garibaldi S; Genazzani AR
Maturitas; 2005 Apr; 50(4):247-58. PubMed ID: 15780523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
